Free Lunchtime Lecture
This talk will focus on:
General drug discovery and development steps
Ivestigational drugs that have been tested in Parkinson’s diseases with the aim to slow the progression of the disease
Possible reasons underlying the failure of the drugs
Kalpana Merchant, PhD had deep expertise in the neurobiology of chronic neurodegenerative and psychiatric disorders. She has nearly 25 years of experience in drug discovery and development with a special emphasis on translational strategies that improve the success rate of drug development.
In March 2014, Kalpana established a life sciences business that provide consultancy services to non-profit foundations and start-up pharmaceutical and biotechnology companies. She continues to remain engaged in training and mentoring of graduate students, postdoctoral scientists and junior faculty through her adjunct academic positions.
Kalpana is engaged in the wider scientific community via her service on NIH Study Sections, Workshops and Advisory Panels, as an advisor to the Michael J. Fox Foundation for Parkinson’s Research, membership of The Wellcome Trust Board as well as several professional societies. Dr. Merchant was also a speaker during the 4th Annual World Parkinson's Congress.
This program presented in partnership with the Portland Parkinson's Program, The Oregon Clinic, and Legacy Health.